Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.58 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.58 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.58 |
| ▸ | DEGS1 | O15121 | 2/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.52 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.52 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.51 |
| ▸ | NAMPT | P43490 | 2/20 | 0.49 |
| ▸ | TAOK1 | Q7L7X3 | 1/20 | 0.48 |
| ▸ | TAOK3 | Q9H2K8 | 1/20 | 0.48 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.48 |
| ▸ | PPARD | Q03181 | 2/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | CCR5 | P51681 | 1/20 | 0.46 |
| ▸ | MLYCD | O95822 | 1/20 | 0.45 |
| ▸ | GCGR | P47871 | 3/20 | 0.45 |
| ▸ | GIPR | P48546 | 3/20 | 0.45 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | PPARA | Q07869 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15087727 | 0.84 | HDAC8 (0.56) | HDAC6HDAC8HDAC1DEGS1HDAC3 | |
| SCHEMBL13061385 | 0.81 | HDAC6 (0.59) | HDAC6HDAC8HDAC1DEGS1HDAC3 | |
| SCHEMBL7332673 | 0.78 | HDAC8 (0.69) | HDAC6HDAC8HDAC1DEGS1HDAC3 | |
| SCHEMBL17660271 | 0.77 | MLYCD (0.56) | HDAC6HDAC8HDAC1HDAC3HDAC11 | |
| SCHEMBL14880018 | 0.76 | HDAC6 (0.96) | HDAC6HDAC8HDAC1DEGS1HDAC3 | |
| SCHEMBL9892966 | 0.76 | HDAC8 (0.71) | HDAC6HDAC8HDAC1DEGS1HDAC3 | |
| SCHEMBL26154128 | 0.75 | HDAC8 (0.60) | HDAC6HDAC8HDAC1DEGS1HDAC3 | |
| SCHEMBL10283170 | 0.74 | HDAC8 (0.69) | HDAC6HDAC8HDAC1DEGS1HDAC3 | |
| SCHEMBL6392195 | 0.74 | HDAC8 (0.63) | HDAC6HDAC8HDAC1DEGS1HDAC3 | |
| SCHEMBL7742573 | 0.74 | CXCR4 (0.59) | HDAC6HDAC8HDAC1DEGS1HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9487494-B2 | Cyclic hydrocarbon compounds for the treatment of diseases | LEO PHARMA A/S (DK) | 2016-11-08 | — | — | US | disclosed |
| US-20100317582-A1 | NOVEL CYCLIC HYDROCARBON COMPOUNDS FOR THE TREATMENT OF DISEASES | LEO PHARMA A/S (DK) | 2010-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317582-A1 | NOVEL CYCLIC HYDROCARBON COMPOUNDS FOR THE TREATMENT OF DISEASES | ARNT, AHR, CYP27A1 | HDAC6 1441/4885HDAC8 1817/4885HDAC1 1388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.